Plasma oxysterols are associated with serum lipids and dementia risk in older women
- PMID: 38574442
- PMCID: PMC11095475
- DOI: 10.1002/alz.13811
Plasma oxysterols are associated with serum lipids and dementia risk in older women
Abstract
Introduction: Apolipoprotein E4 (APOE4) carriers' tendency toward hypercholesterolemia may contribute to Alzheimer's disease (AD) risk through oxysterols, which traverse the blood-brain barrier.
Methods: Relationships between baseline plasma oxysterols, APOE status, serum lipids, and cognitive impairment risk were examined in 328 postmenopausal women from the Women's Health Initiative Memory Study. Women were followed for 25 years or until incident dementia or cognitive impairment.
Results: Levels of 24(S)-hydroxycholesterol (24-OHC), 27-hydroxycholesterol (27-OHC), and 24-OHC/27-OHC ratio did not differ by APOE status (p's > 0.05). Higher 24-OHC and 27-OHC were associated with higher total, low density lipoprotein (LDL), non-high density lipoprotein (HDL), remnant, LDL/HDL, and total/HDL cholesterol and triglycerides (p's < 0.05). Higher 24-OHC/27-OHC was associated with greater dementia risk (hazard ratio = 1.51, 95% confidence interval:1.02-2.22), which interaction analyses revealed as significant for APOE3 and APOE4+, but not APOE2+ carriers.
Discussion: Less favorable lipid profiles were associated with higher oxysterol levels. A higher ratio of 24-OHC/27-OHC may contribute to dementia risk in APOE3 and APOE4+ carriers.
Keywords: 24‐hydroxycholesterol; 27‐hydroxycholesterol; Alzheimer's disease; Apolipoprotein E; Women's Health Initiative Memory Study; cholesterol; dementia; mild cognitive impairment; oxysterols.
© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors report no conflicts of interest. Author disclosures are available in the supporting information.
References
-
- Chartier‐Harlin M‐C, Parfitt M, Legrain S, et al. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late‐onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994;3(4):569‐574. - PubMed
-
- Boerwinkle E, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet. 1987;51(3):211‐226. doi:10.1111/j.1469-1809.1987.tb00874.x - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201600002C/HL/NHLBI NIH HHS/United States
- HHSN268201600018C/HL/NHLBI NIH HHS/United States
- RF1 AG079149/AG/NIA NIH HHS/United States
- R01 AG074345/AG/NIA NIH HHS/United States
- RF1AG079149/AG/NIA NIH HHS/United States
- HHSN268201600004C/HL/NHLBI NIH HHS/United States
- HHSN268201600001C/HL/NHLBI NIH HHS/United States
- RF1 AG074345/AG/NIA NIH HHS/United States
- P30 AG072947/AG/NIA NIH HHS/United States
- RF1AG074345/AG/NIA NIH HHS/United States
- HHSN268201600003C/HL/NHLBI NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
